Crescendo Bioscience, creators of the Vectra DA blood test to predict the progression of rheumatoid arthritis (RA), is gaining market share in the United States, with its new parent company, Myriad ...

Add Yahoo as a preferred source to see more of our stories on Google. Although there are more than 100 conditions that fall under the umbrella term "arthritis," an autoimmune disease called rheumatoid ...

Scientists at Queen Mary, University of London, have announced a new machine-learning-based method for predicting the biological therapy, or biologic, most likely to successfully relieve symptoms for ...

Lake Charles, LA (KPLC) - Rheumatoid arthritis is a progressive autoimmune disease that if left untreated, can attack the joints and internal organs. There are medications that can help block the ...

Please provide your email address to receive an email when new articles are posted on . The American College of Rheumatology has added the Vectra blood test, developed by Myriad Genetics, to its list ...

Seven years ago, Northeastern graduate Susan Dina Ghiassian was the first employee of Scipher Medicine Corp., a precision medicine company co-founded by Northeastern professor Albert-László Barabási.

WALTHAM, Mass.--(BUSINESS WIRE)--Scipher Medicine, a precision immunology company matching each patient with their most effective therapy, today announced new data showing patients with rheumatoid ...